Ke Geng

O'Melveny & Myers LLP - CHINA


Ke Geng's competencies

Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Equity Capital MarketsCHINA16190017918
Practice AreaJurisdictionRankAgg. Deals ValueClients DimensionN. of TransactionsLast Quarter
Showing 1 to 1 of 1 entries

Client Reviews

The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessment


Communication Skills

0255075100Below expectationMeet expectationExceed expectation0

Technical skills

0255075100Below expectationMeet expectationExceed expectation0

Efficiency

0255075100Below expectationMeet expectationExceed expectation0


Effectiveness

0255075100Below expectationMeet expectationExceed expectation0



Perceived Added Value

0255075100

Ranking 2022: Ke Geng - O'Melveny & Myers LLP

Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Equity Capital Markets2095160510
Practice AreaAgg. Deals ValueClients DimensionN. of TransactionsTier
Showing 1 to 1 of 1 entries

Ranking 2021: Ke Geng - O'Melveny & Myers LLP

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Equity Capital Markets351012149
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Ranking 2020: Ke Geng - O'Melveny & Myers LLP

Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier
Corporate M&A85251
Equity Capital Markets7001257
Practice Area Agg. Deals Value Clients Dimension N. of Transactions Tier

Significant Clients

The chart shows a balanced list of the Ke  Geng's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve Mounths
US Tiger SecuritiesTYK MedicinesTianhui BiotechTaimeiSunho BiologicsShanghai REFIRE Group LimitedRuichang International Holdings LimitedQunabox Group Limited Laopu Gold Co. Ltd.Deutsche BankChina International CapitalCorporation Limited (CICC)China International CapitalCorporation Hong Kong SecuritiesLimitedChenghe Acquisition II Co.05K10KRevenue (ML. Euro)

Team

The chart shows a balanced list of counselor working with Ke  Geng - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Ke ZhuYazhe LiuSean SyWilliam SunVincent WangSabrina HePenny ChenKeren HeRobert Plesnarski Qianyu HuNingzhi ChenMichelle YeKatherine WangFan WuYe SunWuxiao LiangWendy KanVincent LinStella HuPriscilla YeungPianpian ChenNorman LukLuc MoritzKurt BerneyJingwei HuangJhe-yu SuJeffrey HangJeeho LeeJames HarriganEdward PoonDawn Lim Chao DengBilly AbbottArsalan MemonAnn Marie ChoyAaron Xin0310620Agg. deal value (ML. Euro)

Co-Counsel

The Chart shows a balanced list of Ke  Geng's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve Mounths
Maples and CalderJunHeZhong Lun Law FirmAllbright04080Agg. deal value (ML. Euro)

Counterparts

The Chart shows a balanced list of Ke  Geng's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve Mounths
LinklatersAshurstHerbert Smith FreehillsBaker McKenzie075150Agg. deal value (ML. Euro)

Peer Reviews

The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessment


0%20%40%60%80%100%Communication SkillsTechnical skillsEfficiencyEffectivenessPerceived Added Value

Recent experiences

Tianhui Biotech and Oramed Pharmaceuticals' Investment in OraTech Pharmaceuticals3/11/2025
Shanghai REFIRE Group's Global Offering12/9/2024
Tiger Brokers Shares' US$108 Million Follow-on Public Offering11/27/2024
Zhejiang Taimei Medical Technology's Initial Public Offering10/17/2024
TYK Medicines' US$74 Million Hong Kong IPO9/17/2024
Ruichang International's HK$131 Million Hong Kong IPO7/22/2024
Shanghai Voicecomm Information Technology's US$85 Million Initial Public Offering7/22/2024
Chenghe Acquisition II's US$86 Million Initial Public Offering7/19/2024